Advanced search
Publication Cover
Artificial Cells, Blood Substitutes, and Biotechnology Volume 35, 2007 - Issue 5
Journal homepage
486
Views
27
CrossRef citations to date
0
Altmetric
Original

Polyhemoglobin-Fibrinogen: A Novel Oxygen Carrier with Platelet-Like Properties in a Hemodiluted Setting

Naomi S. W. Wong Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
&
Thomas M. S. Chang Artificial Cells and Organs Research Centre, Departments of Physiology, Medicine and Biomedical Engineering, Faculty of Medicine, McGill University, Montreal, Quebec, CanadaCorrespondence[email protected]
Pages 481-489 | Published online: 11 Jul 2009

REFERENCES

  • Chang, T.M.S. (1971). Stabilization of enzyme by microencapsulation with a concentrated protein solution or by crosslinking with glutaraldehyde. Biochem Biophys. Res. Com. 44: 1531–1533.
  • Gould, S.A. , et al. (2002). The life-sustaining capacity of human polymerized Hb when red cells might be unavailable. J. Am. Coll. Surg. 195: 445–452.
  • Pearce, L.B., Gawryl, M.S., Rentko, V.T., Moon-Massat, P.F., Rausch C.W. (2006). HBOC-201 (Hb Glutamer-250 (bovine), hemopure): Clinical studies. in Blood Substitutes, R. Winslow, Ed., Academic Press: San Diego, pp. 437–450.
  • Kjellstrom, B.T. (2003). Blood substitutes: Where do we stand today? Journal of Internal Medicine 253: 495–497.
  • Chang, T.M.S. (2006). Nanobiotechnology-based blood substitutes. Trends in Biotechnology 24: 72–377.
  • Busch, M.P., , et al. (2003). Current and emerging infectious risks of blood transfusions. JAMA 289(8): 959–961.
  • Moore, E.E. (2003). Blood substitutes: The future is now. Journal of American College of Surgeons 196(1): 1–17.
  • Chang, T.M.S. (2007). Artificial Cells: Biotechnology, Nanotechnology, Blood Substitutes, Regenerative Medicine, Bioencapsulation, Cell/Stem Cell Therapy, World Scientific Publisher: Singapore.
  • Leytin, V., , et al. (2003). Hemolink, an o-raffinose cross-linked haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood in vitro. British Journal of Haematology 120: 535–541.
  • Lee, D.H., Blajchman, M.A. (2000). Platelet substitutes and novel platelet products. Expert Opinion on Investigational Drugs 9(3): 457–469.
  • Lapierre, V., Herve, P. (1999). Perspectives. La Presse Medicale 28(4): 1336–1340.
  • Lee, R.I., White, P.D. (1913). A clinical study of the coagulation time of blood. The American Journal of Medical Sciences 145: 495–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.